This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 23820457
Submitted by lobbyist on: May 20, 2015 08:39:29 AM
Accepted by Registrar on: May 20, 2015 01:26:13 PM
Lobbyist Information
Resnick, Mark |
100-46 Elgin Street | |
Ottawa, ON, K1P 5K6
|
613-567-8967 |
Canada |
BC Public Office Background
This individual has not held any public office positions in BC.
Lobbyist Firm Information
The Rothwell Group |
100-46 Elgin Street | |
Ottawa, ON, K1P 5K6
|
613-567-8967 |
Canada |
Client Information
Purdue Pharma Canada |
Brand name pharmaceutical manufacturer |
575 Granite Court | |
Pickering, ON, L1W 3W8
|
905-421-3305 |
Canada |
Relevant Affiliates
The client has no relevant affiliates.
Government or Government Agency Funding
The organization does not receive any funding from a government or government agency.
Other Controlling or Directing Interests
The organization has no other controlling or directing interests.
Undertaking Information
May 20, 2015 | |
December 31, 2015 |
There are no other individuals engaged to lobby on this undertaking.
Lobbying Activities
Health
Arranging meeting between an individual and a public office holder
Familiarizing Officials about the benefits associated with abuse deterrent formulations of prescription opiods
Target Contacts
Target Type | Name | Title or Constituency | Date Added |
---|---|---|---|
Staff of Minister | Minister of Health | May 20, 2015 |